Free shipping on all orders over $ 500

Rauwolscine hydrochloride

Cat. No. M20474
Rauwolscine hydrochloride Structure
Synonym:

Isoyohimbine hydrochloride, α-Yohimbine hydrochloride, corynanthidine hydrochloride

Size Price Availability Quantity
50mg USD 150  USD150 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Rauwolscine hydrochloride is the hydrochloride salt form of Rauwolscine, a specific and potent α2 antagonist with Ki of 12 nM.

Chemical Information
Molecular Weight 390.90
Formula C21H27ClN2O3
CAS Number 6211-32-1
Solubility (25°C) DMSO 7 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Ting Fu, et al. J Dermatol Sci. Yohimbine hydrochloride inhibits skin melanin synthesis by regulating wnt/β-catenin and p38/MAPK signal pathways

[2] Megan E Barnes, et al. Int J Environ Res Public Health. Effects of Acute Yohimbine Hydrochloride Supplementation on Repeated Supramaximal Sprint Performance

[3] Yani Zhao, et al. Eur J Pharmacol. Yohimbine hydrochloride inhibits benign prostatic hyperplasia by downregulating steroid 5α-reductase type 2

[4] Chunyan Wang, et al. Mol Med Rep. Dexmedetomidine alleviated sepsis‑induced myocardial ferroptosis and septic heart injury

[5] Michael G Ziegler, et al. Hypertension. New therapies for postural hypotension

Related Adrenergic Receptor Products
CRN04894

CRN04894 is an orally nonpeptide, potent and selective antagonist for adrenocorticotropic hormone (ACTH) acting at the melanocortin 2 receptor (MC2R). CRN04894 blocks the action of ACTH at MC2R, providing a potential novel treatment for the diseases of ACTH excess such as Cushing’s disease, congenital adrenal hyperplasia, and ectopic ACTH-secreting tumors.

(Des-His6)-ACTH (1-24) (human, bovine, rat)

(Des-His6)-ACTH (1-24) (human, bovine, rat) is an analogue of Adrenocorticotropic hormone (ACTH).

ACTH (1-14)

ACTH (1-14) is a fragment of adrenocorticotrophin, which regulates cortisol and androgen production.

Mibenratide

Mibenratide, a small cyclic peptide, is an adrenergic β1 receptor antagonist.

Conopeptide rho-TIA

Conopeptide rho-TIA is a peptide derived from the venom contained in the predatory sea snail Conus tulipa, has highly selective and noncompetitive inhibitor at human α1B-Adrenergic Receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Rauwolscine hydrochloride, Isoyohimbine hydrochloride, α-Yohimbine hydrochloride, corynanthidine hydrochloride supplier, Adrenergic Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.